"He went through six operations and was placed on a clinical trial so he could try new treatments.”
A trial looking at the genetic causes of brain tumours - National Brain Tumour (NBT) Study
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This study looked at blood samples to find out more about the genetic causes of brain tumours.
More about this trial
Doctors want to find other genetic changes (mutations) that may increase the risk of brain tumours, and may be slightly more common. They hope that in the future this could help diagnose brain tumours earlier, and help develop new treatments.
In this study, the research team collected blood samples from people who had brain tumours, and people who didn’t. They compared the genetic changes in the two groups to help identify differences that may affect someone’s risk of developing a brain tumour.
Summary of results
- 5,637 people who had a brain tumour
- 9,158 people who didn’t have a brain tumour
- 12,496 people who had a brain tumour
- 18,190 people who didn’t have a brain tumour
- 1 linked to a type of brain tumour called a glioblastoma
- 4 linked to non glioblastoma brain tumours
- 5 linked to glioblastoma
- 8 linked to non glioblastoma brain tumours
- just over a quarter of the inherited risk (27%) of developing glioblastoma
- more than a third of the inherited risk (between 37% and 43%) of developing non glioblastoma
How to join a clinical trial
Professor Richard Houlston
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
NIHR Clinical Research Network: Cancer
National Cancer Research Institute (NCRI)
National Institutes of Health (NIH)